{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:11:34Z","timestamp":1762146694942,"version":"build-2065373602"},"reference-count":67,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-13430"],"award-info":[{"award-number":["MOP-13430"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000092","name":"Ontario Genomics Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R24 CA78088"],"award-info":[{"award-number":["R24 CA78088"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.yexcr.2007.03.023","type":"journal-article","created":{"date-parts":[[2007,4,2]],"date-time":"2007-04-02T07:12:44Z","timestamp":1175497964000},"page":"2134-2143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Phenomics and lamins: From disease to therapy"],"prefix":"10.1016","volume":"313","author":[{"given":"Robert A.","family":"Hegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2007.03.023_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0503-15","article-title":"The human phenome project","volume":"34","author":"Freimer","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0166-2236(02)02250-6","article-title":"Phenomics: fiction or the future?","volume":"25","author":"Gerlai","year":"2002","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2004.02.001","article-title":"Phenomics, lipodystrophy, and the metabolic syndrome","volume":"14","author":"Hegele","year":"2004","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib4","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1164\/ajrccm.156.4.12-tac-5","article-title":"Genetics of complex disease: approaches, problems, and solutions","volume":"156","author":"Schork","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ncpcardio0638","article-title":"Genetic determinants of the metabolic syndrome","volume":"3","author":"Pollex","year":"2006","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1152\/physrev.1995.75.3.473","article-title":"Pathophysiology of insulin resistance in human disease","volume":"75","author":"Reaven","year":"1995","journal-title":"Physiol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.yexcr.2007.03.023_bib7","first-page":"78","article-title":"Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity","volume":"32","author":"Juhan-Vague","year":"2000","journal-title":"Ann. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib8","first-page":"23","article-title":"Insulin resistance, heart disease and inflammation. Identifying the \u2018at-risk\u2019 patient: the earlier the better? The role of inflammatory markers","author":"Koenig","year":"2002","journal-title":"Int. J. Clin. Pract., Suppl."},{"key":"10.1016\/j.yexcr.2007.03.023_bib9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2007.03.023_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"article-title":"Conclusions from the 2004 IDF Consensus on the Metabolic Syndrome","year":"2005","author":"Alberti","key":"10.1016\/j.yexcr.2007.03.023_bib12"},{"key":"10.1016\/j.yexcr.2007.03.023_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1086\/302836","article-title":"Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A\/C","volume":"66","author":"Speckman","year":"2000","journal-title":"Am. J. Hum. Genet."},{"issue":"Suppl. 1","key":"10.1016\/j.yexcr.2007.03.023_bib16","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/sj.ijo.0802911","article-title":"Lessons from human mutations in PPARgamma","volume":"29","author":"Hegele","year":"2005","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.yexcr.2007.03.023_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/505885","article-title":"Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy","volume":"79","author":"Hegele","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jmg.23.2.120","article-title":"Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state","volume":"23","author":"Kobberling","year":"1986","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib19","first-page":"170","article-title":"Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety)","volume":"84","author":"Garg","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2007.03.023_bib20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.103.18.2225","article-title":"Premature atherosclerosis associated with monogenic insulin resistance","volume":"103","author":"Hegele","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2007.03.023_bib21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1161\/01.ATV.0000047460.27435.B8","article-title":"Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A\/C (LMNA) with partial lipodystrophy","volume":"23","author":"Hegele","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yexcr.2007.03.023_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568008033340117","article-title":"Stearoyl-CoA desaturase-1 and the metabolic syndrome","volume":"3","author":"Cohen","year":"2003","journal-title":"Curr. Drug Targets Immune Endocr. Metabol. Disord."},{"key":"10.1016\/j.yexcr.2007.03.023_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1517\/13543784.12.9.1489","article-title":"Novel peroxisome proliferator-activated receptor ligands for type 2 diabetes and the metabolic syndrome","volume":"12","author":"Miller","year":"2003","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.yexcr.2007.03.023_bib24","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1517\/14656566.4.11.1901","article-title":"Pharmacotherapy for dyslipidaemia \u2013 current therapies and future agents","volume":"4","author":"Bays","year":"2003","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.yexcr.2007.03.023_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2342-7-3","article-title":"Quantitative and qualitative differences in subcutaneous adipose tissue stores across lipodystrophy types shown by magnetic resonance imaging","volume":"7","author":"Al-Attar","year":"2007","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.yexcr.2007.03.023_bib26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1399-0004.2005.00447.x","article-title":"LMNA mutation position predicts organ system involvement in laminopathies","volume":"68","author":"Hegele","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib28","doi-asserted-by":"crossref","first-page":"6699","DOI":"10.1210\/jc.2005-0939","article-title":"Phenotypic heterogeneity in body fat distribution in patients with atypical Werner's syndrome due to heterozygous Arg133Leu lamin A\/C mutation","volume":"90","author":"Jacob","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2007.03.023_bib29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1001\/archneur.61.5.690","article-title":"Extreme variability of phenotype in patients with an identical missense mutation in the lamin A\/C gene: from congenital onset with severe phenotype to milder classic Emery\u2013Dreifuss variant","volume":"61","author":"Mercuri","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.yexcr.2007.03.023_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(03)14069-X","article-title":"LMNA mutations in atypical Werner's syndrome","volume":"362","author":"Chen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2007.03.023_bib31","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00047.2005","article-title":"Nuclear lamins: laminopathies and their role in premature ageing","volume":"86","author":"Broers","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yexcr.2007.03.023_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymgme.2005.10.018","article-title":"Laminopathies: multisystem dystrophy syndromes","volume":"87","author":"Jacob","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.yexcr.2007.03.023_bib33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/jmg.2004.019661","article-title":"Homozygous missense mutation in the lamin A\/C gene causes autosomal recessive Hutchinson\u2013Gilford progeria syndrome","volume":"41","author":"Plasilova","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","article-title":"Genetic basis of lipodystrophies and management of metabolic complications","volume":"57","author":"Agarwal","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1152\/physiolgenomics.00060.2005","article-title":"Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy","volume":"23","author":"Filesi","year":"2005","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.yexcr.2007.03.023_bib36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1126\/science.1127168","article-title":"Lamin A-dependent nuclear defects in human aging","volume":"312","author":"Scaffidi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2007.03.023_bib37","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/ncb1104-1062","article-title":"A-type lamins: guardians of the soma?","volume":"6","author":"Hutchison","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2007.03.023_bib38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200419670","article-title":"Lamin A\/C deficiency causes defective nuclear mechanics and mechanotransduction","volume":"113","author":"Lammerding","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2007.03.023_bib39","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.1073\/pnas.0601058103","article-title":"Distinct structural and mechanical properties of the nuclear lamina in Hutchinson\u2013Gilford progeria syndrome","volume":"103","author":"Dahl","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib40","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1242\/jcs.03180","article-title":"Changes in lamina structure are followed by spatial reorganization of heterochromatic regions in caspase-8-activated human mesenchymal stem cells","volume":"119","author":"Raz","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib41","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1007\/s00018-005-5318-6","article-title":"Rescue of heterochromatin organization in Hutchinson\u2013Gilford progeria by drug treatment","volume":"62","author":"Columbaro","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib42","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1073\/pnas.0602569103","article-title":"Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging","volume":"103","author":"Shumaker","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib43","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1101\/gad.842600","article-title":"Nuclear organization of DNA replication in primary mammalian cells","volume":"14","author":"Kennedy","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.yexcr.2007.03.023_bib44","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1128\/MCB.02464-05","article-title":"Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest","volume":"26","author":"Nitta","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexcr.2007.03.023_bib45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies","volume":"11","author":"Lloyd","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib46","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.114.24.4435","article-title":"Properties of lamin A mutants found in Emery\u2013Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy","volume":"114","author":"Ostlund","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib47","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1242\/jcs.114.24.4447","article-title":"Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery\u2013Dreifuss muscular dystrophy","volume":"114","author":"Raharjo","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib48","series-title":"GeneReviews at GeneTests\u00b7GeneClinics: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997\u20132006","article-title":"Emery\u2013Dreifuss muscular dystrophy","author":"Bonne","year":"2004"},{"key":"10.1016\/j.yexcr.2007.03.023_bib49","series-title":"GeneReviews at GeneTests\u00b7GeneClinics: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997\u20132006","article-title":"Hutcinson\u2013Girford progeria syndrome","author":"Brown","year":"2006"},{"key":"10.1016\/j.yexcr.2007.03.023_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/BJ20041359","article-title":"Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24","volume":"387","author":"Corrigan","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2007.03.023_bib51","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1073\/pnas.0511133103","article-title":"Hutchinson\u2013Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody","volume":"103","author":"McClintock","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib52","doi-asserted-by":"crossref","first-page":"13049","DOI":"10.1073\/pnas.192460799","article-title":"Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect","volume":"99","author":"Bergo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng871","article-title":"Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice","volume":"31","author":"Pendas","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib54","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1242\/jcs.03156","article-title":"Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors","volume":"119","author":"Rusinol","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib55","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0506001102","article-title":"Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson\u2013Gilford progeria syndrome","volume":"102","author":"Capell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib56","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/hmg\/ddi326","article-title":"Incomplete processing of mutant lamin A in Hutchinson\u2013Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition","volume":"14","author":"Glynn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib57","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.0503712102","article-title":"Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson\u2013Gilford progeria syndrome","volume":"102","author":"Mallampalli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib58","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1242\/jcs.03263","article-title":"DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A","volume":"119","author":"Liu","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2007.03.023_bib59","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0505767102","article-title":"Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes","volume":"102","author":"Toth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib60","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1073\/pnas.0504641102","article-title":"Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson\u2013Gilford progeria syndrome mutation","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2007.03.023_bib61","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI28968","article-title":"A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson\u2013Gilford progeria syndrome mutation","volume":"116","author":"Yang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2007.03.023_bib62","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1124875","article-title":"A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria","volume":"311","author":"Fong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2007.03.023_bib63","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/hmg\/ddl172","article-title":"Compound heterozygosity for mutations in LMNA causes a progeria syndrome without prelamin A accumulation","volume":"15","author":"Verstraeten","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1194\/jlr.R500012-JLR200","article-title":"Lipid posttranslational modifications. Farnesyl transferase inhibitors","volume":"47","author":"Basso","year":"2006","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.yexcr.2007.03.023_bib65","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00439-005-0051-7","article-title":"Correction of cellular phenotypes of Hutchinson\u2013Gilford progeria cells by RNA interference","volume":"118","author":"Huang","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.yexcr.2007.03.023_bib66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm1204","article-title":"Reversal of the cellular phenotype in the premature aging disease Hutchinson\u2013Gilford progeria syndrome","volume":"11","author":"Scaffidi","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2007.03.023_bib67","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1073\/pnas.0600012103","article-title":"Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson\u2013Gilford progeria syndrome","volume":"103","author":"Varga","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482707001449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482707001449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:07:19Z","timestamp":1762146439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482707001449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":67,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0014482707001449"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2007.03.023","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2007,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenomics and lamins: From disease to therapy","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2007.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}